Literature DB >> 1062969

Myelomonocytic leukaemia following cyclophosphamide therapy of rheumatoid disease.

R R Love, J M Sowa.   

Abstract

A 69-year-old woman treated for 31 months with daily oral cyclophosphamide for refractory rheumatoid disease developed acute myelomonocytic leukemia 21/2 years after stopping the drug. The possibility of a casual association between the therapy and subsequent leukaemia is supported by the growing experience with cytotoxic agents.

Entities:  

Mesh：

Substances：

Year:  1975        PMID： 1062969      PMCID： PMC1006477          DOI： 10.1136/ard.34.6.534

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


  4 in total

1.  Leukaemogens.

Authors:  J D ABBATT; A J LEA
Journal:  Lancet       Date:  1958-10-25       Impact factor: 79.321

2.  Development of reticulum cell sarcoma during cyclophosphamide therapy.

Authors:  H Tannenbaum; P H Schur
Journal:  Arthritis Rheum       Date:  1974 Jan-Feb

3.  Immunosuppressive drugs and acute leukemia.

Authors:  C D Cobau; R P Sheon; A B Kirsner
Journal:  Ann Intern Med       Date:  1973-07       Impact factor: 25.391

4.  Guidelines for the use of cytotoxid drugs in rheumatic diseases.

Authors:  R S Schwartz; J D Gowans
Journal:  Arthritis Rheum       Date:  1971 Jan-Feb
  4 in total
  4 in total

1.  Chronic myelomonocytic leukemia and primary Sjögren's syndrome.

Authors:  T Ponge; F Champetier de Ribes; A Ponge; R Garand; S Cottin
Journal:  Clin Rheumatol       Date:  1988-03       Impact factor: 2.980

2.  The occurrence of malignancies in patients with rheumatoid arthritis treated with cyclophosphamide: a controlled retrospective follow-up.

Authors:  J A Baltus; J W Boersma; A P Hartman; J P Vandenbroucke
Journal:  Ann Rheum Dis       Date:  1983-08       Impact factor: 19.103

3.  Therapeutic workshop on modifying the disease process in rheumatoid arthritis: immunosuppression in perspective.

Authors: 
Journal:  Ann Rheum Dis       Date:  1982       Impact factor: 19.103

4.  Cause of death in patients with rheumatoid arthritis with particular reference to azathioprine.

Authors:  P Lewis; B L Hazleman; R Hanka; S Roberts
Journal:  Ann Rheum Dis       Date:  1980-10       Impact factor: 19.103
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.